UNSPSC 85653040: Supplement right upper leg muscle with nonautologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right upper leg muscle with nonautologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0KUQ4KZ

UNSPSC 85653040 Supplement right upper leg muscle with nonautologous tissue substitute, percutaneous endoscopic approach is a Commodity code that represents a specific surgical procedure classification, but the code shows no relevant recent state and local procurement activity. The six most-recent opportunities posted under this code—independent medical evaluation services for public safety pension disability determinations (City of Phoenix), surgery benefit carve-out programs for municipal employees (City of Long Beach), occupational medical surveillance for ferry workers (Washington State Department of Transportation), emergency and specialty medical services for detained youth (Harris County Juvenile Probation Department), pharmacy benefit management (Collier County), and temporary health professional staffing (County of Santa Clara Health System)—address health plan administration, occupational medicine, emergency care delivery, and clinical staffing, none of which align with orthopedic surgical procedure supply or implant services that the code nominally describes. The mismatch suggests either a tagging error in the underlying procurement data or that this particular code is not actively used by state and local jurisdictions for substantive purchasing.

State and local procurement systems do not routinely acquire specific surgical procedures or tissue-substitute implants through traditional RFP or IFB vehicles; these are typically sourced through hospital supply contracts, group purchasing organization agreements, or vendor-direct relationships managed at the facility or health system level rather than through centralized procurement notices. If your firm supplies orthopedic implants, tissue substitutes, or related surgical materials to public health systems, monitoring this code's activity is unlikely to yield near-term opportunity signals. Redirect prospective activity tracking toward hospital system capital equipment RFPs, health system group purchasing cooperative announcements, or direct outreach to public health system materials management offices.